Fatty Acid Ester Production via Genetically Engineered Microorganisms

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current methods for producing fatty acid esters are inefficient, generate significant by-products, and lack specificity, particularly for methyl laurate production, with environmental concerns associated with petroleum-based extraction and low yields from biofuels.

Innovation Solution

Genetically engineered microorganisms are used to produce fatty acid esters by modifying them to enhance fatty acid and acyl-CoA production through specific enzymatic pathways and increasing wax ester synthase activity, allowing for efficient and specific production of fatty acid esters like methyl laurate in the presence of exogenous alcohols.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Productivity

If petroleum extraction and cracking methods are used to produce fatty acid esters, then production capacity is sufficient, but environmental damage increases and production costs increase due to energy consumption and petroleum price linkage

Engineering Contradiction:
Improveproduction capacityVSAvoidenvironmental damage
Core Design Contradiction:
ProductivityVSObject-affected harmful factors

Solution Approach 1:

The invention changes the fundamental parameter of raw material source from petroleum-based to microorganism-based production. By genetically engineering microorganisms to produce fatty acid esters, the process eliminates the need for petroleum extraction and cracking, thereby reducing environmental damage while maintaining production capacity through controlled biological synthesis

Inventive Principle:
Principle #35Parameter changes

Solution Approach 2:

The invention replaces the mechanical/chemical cracking process with a biological synthesis process. Instead of using high-energy mechanical cracking to break down long chain hydrocarbons, the patent uses genetically engineered microorganisms to biosynthesize fatty acid esters through metabolic pathways, substituting a biological system for a mechanical/chemical one

Inventive Principle:
Principle #28Mechanics substitution (Replace mechanical system)

2Adaptability or versatility

If conventional biofuel methods are used to produce fatty acid esters, then renewable sourcing is achieved, but production yield remains low

Engineering Contradiction:
Improverenewable sourcingVSAvoidproduction yield
Core Design Contradiction:
Adaptability or versatilityVSProductivity

Solution Approach 1:

The invention segments the fatty acid ester production pathway into distinct genetic components that can be independently optimized. By introducing specific genes for fatty acid synthesis and wax ester synthase activity, the patent creates a modular biological system where each component contributes to the overall yield, allowing for targeted improvement of production efficiency while maintaining renewable sourcing

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

The invention creates a composite biological system by combining multiple genetic elements within the microorganism. The engineered microorganism integrates fatty acid synthesis pathways with wax ester synthase expression, creating a composite cellular system that produces fatty acid esters with high yield while maintaining the renewable characteristic of biological production

Inventive Principle:
Principle #40Composite materials

3Ease of manufacture

If current fatty acid ester production methods are used, then basic production capability is maintained, but specificity for particular esters like methyl laurate is poor and by-product generation is high

Engineering Contradiction:
Improvebasic production capabilityVSAvoidspecificity
Core Design Contradiction:
Ease of manufactureVSManufacturing precision

Solution Approach 1:

The invention applies local quality by introducing specific genetic modifications at particular locations in the metabolic pathway. By expressing specific wax ester synthase genes and modifying particular enzymatic steps in fatty acid synthesis, the patent achieves high specificity for methyl laurate production while maintaining overall production capability, reducing unwanted by-products through targeted genetic engineering

Inventive Principle:
Principle #3Local quality

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

This approach significantly increases the yield and specificity of fatty acid ester production, reducing environmental impact and operational costs compared to traditional methods, while minimizing by-product generation.

Implementation Method 1

Fatty acid esters are known to be the product of a condensation reaction between an acyl-CoA molecule and an alcohol of any chain length sometimes in the presence of wax ester synthases

Methodology Applied
Scientific EffectEnzymatic catalysis: Enzyme

Implementation Method 2

Fatty acid esters are known to be the product of a condensation reaction between an acyl-CoA molecule and an alcohol

Methodology Applied
Scientific EffectCondensation reaction: Chemical Bonding

Data Source

PatentUS10494654B2Production of fatty acids esters
Publication Date: 2019.12.03 CARGILL INC
  • US10494654B2 patent drawing
  • US10494654B2 patent drawing
  • US10494654B2 patent drawing

AI summary

A microbial cell is used for producing at least one fatty acid ester, wherein the cell is genetically modified to contain (i) at least one first genetic mutation that enables the cell to produce at least one fatty acid and/or acyl coenzyme A (CoA) thereof by increased enzymatic activity in the cell relative to the wild type cell of malonyl-CoA dependent and malonyl-ACP independent fatty acyl-CoA metabolic pathway, wherein the fatty acid contains at least 5 carbon atoms; and (ii) a second genetic mutation that increases the activity of at least one wax ester synthase in the cell relative to the wild type cell and the wax ester synthase has sequence identity of at least 50% to a polypeptide of SEQ ID NO: 1-8 and combinations thereof or to a functional fragment of any of the polypeptides for catalyzing the conversion of fatty acid and/or acyl coenzyme A thereof to the fatty acid ester.